TABLE 3.
Multiple linear regression analysis for dose-corrected VRC Cmin
| Covariate | Coeffcient | 95% CI | P value | R 2 |
|---|---|---|---|---|
| Age | 0.437 | 0.029, 0.056 | <0.001 | 0.234 |
| CYP2C19 phenotype | ||||
| UM/EM | 0.192 | 0.058, 0.337 | 0.006 | |
| IM/PM | ||||
| PPIs | ||||
| Not concomitantly administered | −0.182 | −0.309, −0.043 | 0.01 | |
| Concomitantly administered | ||||
| Routes of administration | ||||
| Injection | 0.107 | −0.042, 0.296 | 0.14 | |
| Oral |